AbbVie Inc. — Director's Dealing 2013

Feb 8, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AbbVie Inc. (ABBV)
CIK: 0001551152
Period of Report: 2013-02-07

Reporting Person: CHASE WILLIAM J (EVP, Chief Financial Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2013-02-07	Common stock, $0.01 par value	M	2390	$32.0005	Acquired	92139	Direct
2013-02-07	Common stock, $0.01 par value	M	2177	$32.4265	Acquired	94316	Direct
2013-02-07	Common stock, $0.01 par value	F	4188	$37.14	Disposed	90128	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-07	Option (right to buy)	$32.0005	M	2390	Disposed	2013-02-13	Common stock (2390)	Direct
2013-02-07	Option (right to buy)	$32.4265	M	2177	Disposed	2013-02-13	Common stock (2177)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common stock, $0.01 par value	501	Indirect

Footnotes

F1: Held by spouse in the AbbVie Savings Program as of February 7, 2013. The reporting person disclaims beneficial ownership of all securities held by his spouse.